Package 82868-019-60

{"route": ["ORAL"], "spl_id": "48352058-8689-4fd6-e063-6394a90aa200", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["0865f8cf-1d7f-0e67-e063-6294a90a2f4d"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-019-30)", "package_ndc": "82868-019-30", "marketing_start_date": "20240314"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-019-60)", "package_ndc": "82868-019-60", "marketing_start_date": "20231019"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-019-90)", "package_ndc": "82868-019-90", "marketing_start_date": "20250102"}, {"sample": false, "description": "180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-019-96)", "package_ndc": "82868-019-96", "marketing_start_date": "20240219"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "82868-019_48352058-8689-4fd6-e063-6394a90aa200", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "82868-019", "generic_name": "bupropion hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA205794", "marketing_category": "ANDA", "marketing_start_date": "20231019", "listing_expiration_date": "20271231"}